**Core Concept**
Glaucoma treatment involves reducing intraocular pressure (IOP) to prevent optic nerve damage. Various medications and surgical interventions are employed to achieve this goal. The correct answer will identify a treatment modality not typically used for glaucoma.

**Why the Correct Answer is Right**
The primary goal of glaucoma treatment is to lower IOP, which can be achieved through medications that reduce aqueous humor production, increase its outflow, or a combination of both. **Beta-blockers**, **alpha-agonists**, **carbonic anhydrase inhibitors**, **prostaglandin analogs**, and **miotics** are commonly used for this purpose. **Option A: Latanoprost** is a prostaglandin analog that increases aqueous outflow, thereby reducing IOP. **Option B: Timolol** is a beta-blocker that decreases aqueous production. **Option C: Dorzolamide** is a carbonic anhydrase inhibitor that also reduces aqueous production.

**Why Each Wrong Option is Incorrect**
**Option D:** **Pilocarpine** is a miotic that increases aqueous outflow by constricting the pupil and increasing trabecular meshwork outflow. This option is incorrect because pilocarpine is indeed used in glaucoma treatment, albeit less commonly than other options listed.

**Clinical Pearl / High-Yield Fact**
Miotics like pilocarpine can cause accommodative spasm, leading to near vision problems in patients with glaucoma. This is an important consideration when choosing a treatment modality.

**Correct Answer:** D. Pilocarpine